-
Mashup Score: 1Effect of Cancer History on Disability, Unemployment, and Medical Expenditures - The ASCO Post - 11 month(s) ago
By Matthew Stenger Posted: 6/13/2023 10:04:00 PM Last Updated: 6/14/2023 3:13:54 PM In a cross-sectional study reported in JAMA Network Open, Grabowski et al found that among U.S. adults, a history of cancer was associated with an increased risk of disability and unemployment payments and higher medical…
Source: ascopost.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Effect of Cancer History on Disability, Unemployment, and Medical Expenditures https://t.co/cQ7fvDInP3 #cancer #survivorship
-
-
Mashup Score: 0
Friday, June 16, 2023, from 2 to 6 p.m. EST Free, Virtual About the Symposium The Supportive Care Research Committee at the Preston Robert Tisch Brain Tumor Center at Duke is pleased to offer the Supportive Care in Neuro-Oncology Symposium. This is a multidisciplinary event bringing together leaders in the fields of supportive care and…
Source: neurosurgery.duke.eduCategories: Hem/Oncs, Latest HeadlinesTweet-
Happening now, kicking off with the Dina Randazzo Memorial Lecture (Thank you to her for the mark she left on the field) - this year Dr Stephen Ross talks about the use of psychedelics in cancer. https://t.co/OVibuN5rAS @Dukeneurosurg Supportive Care #btsm #braintumors #neuroonc
-
-
Mashup Score: 5Targeted Therapy Delays Growth for IDH-Mutant Glioma - 11 month(s) ago
Neuro-oncologist Ingo Mellinghoff, MD, FACP discusses how his research has led to a new targeted therapy for IDH-mutant glioma – and details how this may mark a paradigm shift in therapeutic options for patients with brain tumors.
Categories: Hem/Onc News and Journals, Latest HeadlinesTweet-
🔬 Important research on #WorldBrainTumorDay: Neuro-oncologist Dr. Ingo Mellinghoff shares how his research has led to a new targeted therapy for IDH-mutant glioma – potentially creating a paradigm shift in therapeutic options for patients w/#braintumors. https://t.co/HhqWHNVkpm
-
-
Mashup Score: 0
A new experimental drug could be an effective treatment for some people with low-grade glioma.
Categories: Hem/Onc News and Journals, Latest HeadlinesTweet-
#Braintumors are among the most difficult cancers to treat. But now a new drug has been shown to slow the growth of low-grade gliomas with a certain gene mutation. Read more about Dr. Ingo Mellinghoff's research: https://t.co/s3zx2sqFdx #ASCO23 https://t.co/yLC8Nhsd4l
-
-
Mashup Score: 0Brain Tumors Are Major Contributor to US Cancer Burden - 11 month(s) ago
Data suggest that brain tumors are the fifth most prevalent cancer type in the US, after female breast cancer, prostate cancer, colorectal cancer, and melanoma.
Source: Cancer Therapy AdvisorCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
#Braintumors are the fifth most prevalent cancer type in the United States, according to a study published in @JournalCancer. https://t.co/cRMrNGTRUO #BrainCancer
-
-
Mashup Score: 5Phenotypic diversity of T cells in human primary and metastatic brain tumors revealed by multiomic interrogation - Nature Cancer - 12 month(s) ago
Joyce and colleagues use bulk and single-cell profiling of T cell phenotypes in human samples from primary brain tumors and brain metastases as a resource for understanding the biology and therapeutic relevance of the brain tumor microenvironment.
Source: NatureCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
🔥ONLINE NOW @NatureCancer “Phenotypic diversity of T cells in human primary and metastatic brain tumors revealed by multiomic interrogation” by @WischnewskiVlad @Johanna_A_Joyce & Co! #Braintumors #Tcells Read it here 👇 https://t.co/HPVCHLWfNM https://t.co/QfvCBqWjzW
-
-
Mashup Score: 0
Device allows delivery of more potent chemotherapies to patients with glioblastomas
Source: www.medpagetoday.comCategories: Latest Headlines, Oncologists2Tweet-
"Results from this phase I clinical trial suggest that #ultrasound treatments can enhance #chemotherapeutic delivery of different agents by up to six times in patients with #braintumors," -- Antonios N. Pouliopoulos of @KingsCollegeLon #OncoTwitter https://t.co/1HV6gogQoS
-
-
Mashup Score: 2Powerful Chemotherapy Drug Reaches Brain Tumors in Humans Using Novel Ultrasound Technology - News Center - 1 year(s) ago
A Northwestern Medicine study used a novel ultrasound device to temporarily open the blood-brain barrier to deliver chemotherapy to treat glioblastoma.
Source: News CenterCategories: Healthcare Professionals, Latest HeadlinesTweet-
Powerful Chemotherapy Drug Reaches #BrainTumors in Humans Using Novel #Ultrasound Technology https://t.co/tAY3RY1xN5 Repeated blood–#brainbarrier opening with an implantable ultrasound device for delivery of albumin-bound paclitaxel in patients with recurrent #glioblastoma: a… https://t.co/3V7K9msI0L
-
-
Mashup Score: 5Medication delivered in a gel stops brain tumors in mice. Could it offer hope for humans? - 1 year(s) ago
Medication delivered by a novel gel cured 100% of mice with an aggressive brain cancer, a striking result that offers new hope for patients diagnosed with glioblastoma, one of the deadliest and most common brain tumors in humans.
Source: medicalxpress.comCategories: General Medicine News, Latest HeadlinesTweet-
Medication delivered in a #gel stops #braintumors in mice. Could it offer hope for humans? @johnshopkins @PNASNews https://t.co/nt4nw3ocLA
-
-
Mashup Score: 0Brain Tumor Awareness Month 2023 | Pacific Neuro Institute - 1 year(s) ago
May is Brain Tumor Awareness Month. “Go Gray in May” and celebrate our patients, their loved ones, and their important journeys.
Source: Pacific Neuroscience InstituteCategories: Hem/Oncs, Latest HeadlinesTweet-
One of our #gograyinmay events is a #carepartner social for loved ones of those impacted by #braintumors on 5/25 at 5pm PST - cohosted by @CancerSupportLA at their beautiful location in Los Angeles. Register online at https://t.co/jQDkO3TGuv #btsm #btam #braincancer #braintumor https://t.co/aqzz1lb10D
-
Preoperative Stereotactic Radiosurgery May Help Patients With Metastatic Brain Tumors Reduce the Risk of Disease Progression and Adverse Effects https://t.co/cQ7fvDIVEB #radonc #btsm #braintumors #oncology